CCEL

Cryo Cell International Inc.

NYSEAdd to watchlist

Healthcare · Medical Care Facilities

$4.40

+$0.15+3.53%

Delayed · 2026-09-18T20:00:00.000Z · marketstack

Aug 24, 2026$4.40

+$0.01+0.23%over 1M

Session

Day range100% of range

$4.00$4.40

Fundamentals

Visualize fundamentals and more

Market cap: 35.44M
P/E ratio: -

Revenue grew −1.31% in FY2025, +10.18% slower than its sector. The median across Healthcare companies this platform tracks is +8.87%.

Risk factors, year on year

Item 1AFeb 2026 10-KFeb 2025

added: 10
dropped: 15
re-drafted: 10

Out of 112 passages in this year’s Item 1A.

New this year

The Company anticipates that its cash and cash equivalents, marketable securities and cash flows from operations, together with external sources of capital will be sufficient to fund its known cash needs for at least the next 12 months. However, cash flows …

24 more passages are on Bespoke

Bespoke Create a free account

Free, no card, and it does not expire. See what the paid plans add

What it says it is exposed to

From Item 1A of its most recent 10-K, filed February 2026.

FDA approval
Litigation
Cybersecurity
Key people
Russia and Ukraine
Tariffs
Currency moves
Debt covenants

And 14 more.

FDA approval
The outcome of clinical trials is inherently uncertain. Clinical development is lengthy and uncertain. Our public blood bank research involves clinical testing, which is expensive, complex and lengthy, and subject to various regulations, including the “Common …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Recent activity

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Updated Sep 18, 2026 · the last close

Cryo Cell International Inc. investor relations

What CCEL has filed with the SEC. This is not Cryo Cell International Inc.’s own investor relations site: these filings are the primary source that site publishes from.

Companies like Cryo Cell International Inc.

Also filed under Medical Care Facilities, ranked by how closely they sit beside CCEL.

THCTenet Healthcare Corp.compare with CCEL
HCAHCA Healthcare, Inc.compare with CCEL
UHS

What it says it is exposed to

From Item 1A of its most recent 10-K, filed February 2026.

FDA approval
Litigation
Cybersecurity
Key people
Russia and Ukraine
Tariffs
Currency moves
Debt covenants

And 14 more.

FDA approval
The outcome of clinical trials is inherently uncertain. Clinical development is lengthy and uncertain. Our public blood bank research involves clinical testing, which is expensive, complex and lengthy, and subject to various regulations, including the “Common …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Universal Health Services Inc.

EHCEncompass Health Corpcompare with CCEL

OPCHOption Care Health, Inc.compare with CCEL

Ask about Cryo Cell International Inc.

The assistant answers from what CCEL has actually filed: 16 annual reports filed with the SEC, 16 Form 4 filings from the last year and 1 fund that holds it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Press one and the answer appears right here on the page, from CCEL's filings and figures. One a day without an account; a free account has its own, and no card.

See how much of Cryo Cell International Inc. each of these investors holds, and every quarter they moved.

Ten seconds. No card. Nothing to cancel.

No card, no broker connection.

Continue with Google

What an account lets you do with Cryo Cell International Inc.

Be told the moment a CCEL insider trades
Put Cryo Cell International Inc. on a watchlist for a free alert, the bell and a daily email, when a Form 4 worth a row is filed, with vesting and automatic tax sales already struck out so what lands is a decision, not paperwork.
The full filing historyMeasure
Ask what growth the price is already betting on
Cryo Cell International Inc.'s income statement, balance sheet and cash flow as filed, and the ratios computed from them, plus a reverse DCF that holds today's price fixed and solves for the growth it requires.
The reverse DCFMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: how big a bet each one is, and by how much it changed.
Every position, sizedMeasure
Interrogate the filing, not the internet
Ask anything about Cryo Cell International Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free account See what the paid plans add

Free, no card, and it does not expire.

9 more events are on Measure

Free, no card, and it does not expire. See what the paid plans add

Risk factors, year on year

Item 1AFeb 2026 10-KFeb 2025

added: 10
dropped: 15
re-drafted: 10

Out of 112 passages in this year’s Item 1A.

New this year

The Company anticipates that its cash and cash equivalents, marketable securities and cash flows from operations, together with external sources of capital will be sufficient to fund its known cash needs for at least the next 12 months. However, cash flows …

24 more passages are on Bespoke

Bespoke Create a free account

Free, no card, and it does not expire. See what the paid plans add